Search

Author/Creator Hisamatsu, T

1. A201 EFFECT OF MIRIKIZUMAB ON BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT AND REMISSION: RESULTS FROM THE PHASE 3 LUCENT INDUCTION AND MAINTENANCE STUDIES. (7th March 2023)

Authors:
Travis, S; Hibi, T; Hisamatsu, T; Fisher, D; Shan, M; Gibble, T H; Rubin, D; Jones, J
Journal:
Journal of the Canadian Association of Gastroenterology
Issue:
Volume 6(2023)Supplement 1
Page Start:
43
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH CROHN'S DISEASE: 52 WEEK RESULTS FROM THE PHASE 3 FORTIFY STUDY. (21st February 2022)

Authors:
Panaccione, R; Ferrante, M; Feagan, B G; Sandborn, W; Panes, J; Peyrin-Biroulet, L; Colombel, J; Schreiber, S; Dubinsky, M; Baert, F; Hisamatsu, T; Neimark, E; Huang, B; Liao, X; Song, A; Berg, S; Duan, W; Pang, Y; Pivorunas, V; Kligys, K
Journal:
Journal of the Canadian Association of Gastroenterology
Issue:
Volume 5(2022)Supplement 1
Page Start:
43
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. DOP24 Japan prospective multicenter study for optimization of COVID-19 vaccinations based on the immune response and safety profile in Inflammatory Bowel Disease patients: Interim analyses of the J-COMBAT trial. (21st January 2022)

Authors:
Watanabe, K; Hisamatsu, T; Nakase, H; Nagase, K; Matsuura, M; Aoyama, N; Kobayashi, T; Sakuraba, H; Yokoyama, K; Nishishita, M; Esaki, M; Hirai, F; Nagahori, M; Nanjo, S; Omori, T; Tanida, S; Yokoyama, Y; Moriya, K; Maemoto, A; Handa, O
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i074
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. DOP32 Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2). (25th January 2019)

Authors:
Hisamatsu, T; Kato, S; Kunisaki, R; Matsuura, M; Nagahori, M; Motoya, S; Esaki, M; Fukata, N; Inoue, S; Sugaya, T; Sakuraba, H; Hirai, F; Watanabe, K; Kanai, T; Naganuma, M; Nakase, H; Suzuki, Y; Watanabe, M; Hibi, T; Nojima, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S043
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. DOP47 Sustained remission in patients with moderate to severe ulcerative colitis: Results from the Phase 3 UNIFI maintenance study. (25th January 2019)

Authors:
Van Assche, G; Targan, S R; Baker, T; O'Brien, C D; Zhang, H; Johanns, J; Szapary, P; Marano, C; Leong, R W; Rowbotham, D; Hisamatsu, T; Danese, S; Sands, B E; Peyrin-Biroulet, L
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S054
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. DOP83 Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension. (27th May 2021)

Authors:
Abreu, M T; Danese, S; Sandborn, W J; Miao, Y; Tikhonov, I; Zhang, H; Panaccione, R; Hisamatsu, T; Scherl, E J; Leong, R W; Rowbotham, D S; Arasaradnam, R P; Afif, W; Peyrin-Biroulet, L; Sands, B E; Marano, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. DOP83 Normalisation of biomarkers and improvement in clinical outcomes in patients with Crohn's Disease treated with risankizumab in the phase 3 ADVANCE, MOTIVATE, and FORTIFY studies. (21st January 2022)

Authors:
Atreya, R; Feagan, B; Shchukina, O; Jairath, V; Rieder, F; Hisamatsu, T; Siegmund, B; Rizzo, J; Kligys, K; Neimark, E; Song, A; Zambrano, J; Mallick, M; Cheng, E; Armuzzi, A
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i126
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗